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Clinical Forms of
Neurally-Mediated Syncope
Central or peripheral baroreceptor reﬂex abnor-
malities, alterations in neurohumoral mechanisms, orboth, are thought to play a role in causing neurally-
mediated syncope. Because adenosine and its re-
ceptors are involved in some forms of syncope (1–3),
we evaluated the purinergic proﬁle of 4 common
forms of syncope: typical vasovagal syncope (VVS);
situational syncope (which occurs in speciﬁc cir-
cumstances after micturition, defecation, coughing,
swallowing, or gastrointestinal stimulation); carotid
sinus syncope (CSS); and syncope without prodromes
or with very short (2 to 3 s) prodromes and a normal
heart (no prodromes). We compared patients with
neurally-mediated syncope with healthy control
subjects to test the hypothesis that the adenosine
proﬁle differs with the different clinical presentation.
The purinergic proﬁle included an assay of the
baseline adenosine plasma level (APL) and charac-
terization of A2A adenosine receptor (A2A R) expres-
sion and single nucleotide c.1083 C>T polymorphism
(SNP), which is the most common SNP in the A2A
R gene. The method was previously described (1–4).
Clinical and biological characteristics of patients and
control subjects are given in Table 1.
Thus, these ﬁndings demonstrate an association
between adenosine plasmatic levels and unexplained
syncope in patients without prodromes, CSS, and
VVS, who have proﬁles different from normal control
subjects. The clinical manifestation of adenosine de-
pends on its concentration, on adenosine receptor
expression level, and on the presence of receptor
reserve. However, the causal role of this interplay in
the mechanism of syncope is yet to be determined.
Conversely, adenosine is not associated with situa-
tional syncope, which is mainly triggered by well
identiﬁable afferent neural reﬂexes. Patients with
situational syncope showed APL values similar to
those in normal control subjects, although they had
high A2A R expression and a higher rate of the TT
variant. The purinergic proﬁle of situational syncope
patients was never investigated.
Syncope without prodromes and CSS (which is a
similar form of syncope without prodromes or very
short prodromes and an absence of known triggers)
have a similar distinct proﬁle. In these 2 forms, the
role of adenosine may potentially be important in
causing syncope. When APL values are very low,
as in these clinical forms, and are mainly below or
approximately at the KD value for A1A adenosine re-
ceptor (A1 R) of 0.7 mM, even a modest acute increase
in APL may recruit a sufﬁcient number of A1 R, which
is known to be located within the sinus node and in
the atrioventricular node. Their activation causes si-
nus bradycardia and/or atrioventricular block.
For patients with typical VVS, a combination of
neural outﬂow and purinergic activation is likely.
TABLE 1 Clinical Characteristics of the Study Population and Purinergic Proﬁle
No Prodromes,
Normal Heart
(n ¼ 57)
Carotid Sinus
(n ¼ 9)
Situational
(n ¼ 23)
Vasovagal
(n ¼ 30)
Control Subjects
(n ¼ 40)
Age, yrs 64  15* 74  10* 56  18 45  17* 53  15
Women 36 (63) 2 (22) 8* (35) 18 (60%) 23 (57)
Total number of syncopes 3 (2–5) 2 (2–3) 4 (2–6.5) 8† (4–15) —
Duration of symptoms, yrs 1 (1–3) 1 (1–2) 4 (1.5–10) 10† (3–22) —
APL, mM 0.18* (0.12–0.36) 0.16* (0.10–0.31) 0.60 (0.43–0.70) 0.85* (0.59–1.90) 0.60 (0.50–0.69)
APL #0.36 mM‡ 45* (79%) 8* (89%) 5* (22%) 2 (7%) 1 (2%)
A2A R expression, arbitrary units 0.5* (0.3–0.6)
(n ¼ 16)
0.5 (0.4–0.5)
(n ¼ 6)
0.9* (0.9–1.0)
(n ¼ 7)
0.8* (0.7–1.0)
(n ¼ 11)
0.7 (0.5–0.8)
(n ¼ 40)
SNP:TT/TC/CC variants 2/20/5 1/4/3 12/5/2* 0/5/9 7/20/13
Tilt table test, hypotension þ bradycardia
response
13/56 (23%) 2/6 (33%) 8/23 (35%) 22/30§ (73%) —
Values are mean  SD, n (%), or n (ranges). *p < 0.05 compared with control subjects; †p < 0.05 vasovagal compared with no prodromes and carotid sinus; ‡Value
corresponding to the best receiving-operating characteristic curve discriminant [see Deharo et al. (2)]; §p < 0.05 vasovagal compared with each other group.
APL ¼ adenosine plasma level; A2A R ¼ adenosine A2A receptor; SNP ¼ single nucleotide c.1364 C>T polymorphism.
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with the activation of low afﬁnity A2A R activa-
tion (KD 1.8 mM) and desensitization of high afﬁnity
A1 R. Low afﬁnity A2A R is located in the vessels and
causes vasodilation. Thus, syncope may be related
to the vasodilatory effect of the A2A R activation,
which acts synergically with the blunted sympa-
thetic nervous activity. Interestingly, these patients
also showed a high incidence of positive tilt tests. It
is known that a positive tilt test denotes suscepti-
bility to hypotension (5).
In conclusion, particular purinergic proﬁles, which
are genetically predetermined, characterize different
common forms of neurally-mediated syncope that
can be classiﬁed as low, normal, and high adenosine
syncope; this classiﬁcation might have therapeutic
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A Risk Factor in Brugada SyndromeConte et al. (1) reported their long-term results
of implantable cardioverter-deﬁbrillator therapy
in Brugada syndrome (BS). The investigators noted
that 4 patients experienced an electrical storm
and 1 (Patient #3) had a “fragmentation of the QRS
complex (f-QRS).” In fact, this patient’s electrocar-
diogram (ECG) showed a spike mainly at the terminal
portion of all QRS complexes. After ajmaline chal-
lenge, a coved-type ECG was induced, and the spike
disappeared, unmasking an S wave in leads V4 to V6.
We believe that the terminal QRS spike may signify
early repolarization (ER) rather than f-QRS in this BS
patient. Unlike in myocardial infarction, f-QRS has
